- Posted Wednesday October 15, 2008
TGen's Dr. Von Hoff is a finalist for prestigious Arizona technology community service award
PHOENIX, Ariz. - Oct. 15, 2008 -- Dr. Daniel Von Hoff, TGen's Physician-in-Chief, is one of three nominees for the 2008 William F. McWhortor Community Service Leader of the Year award.
The McWhortor award is presented annually to an individual or organization from industry, government or academia that contributes to Arizona's technology industry through relentless community involvement, leadership, visibility and excellence in economic development activity.
The winner will be announced during the Governor's Celebration of Innovation from 5-7 p.m. Nov. 13 at the Dodge Theatre, 400 W. Washington St., Phoenix. The awards are organized through the Governor's Office, the Arizona Department of Commerce and the Arizona Technology Council.
"We congratulate Dr. Von Hoff on the honor of being nominated for this prestigious award," said Steven G. Zylstra, president and CEO of the Arizona Technology Council. "He has demonstrated extraordinary creativity and collaboration and his work has fuelled significant growth within the Arizona technology community."
Dr. Von Hoff also is Chief Scientific Officer of TGen Clinical Research Services at Scottsdale Healthcare, Clinical Professor of Medicine at the University of Arizona, and a member of the Mayo Clinic's Comprehensive Cancer Center.
In addition to being an accomplished and recognized cancer scientist, Dr. Von Hoff has been tireless in what he has brought to the Arizona community. He is a founder of TGen, a founder of the non-profit International Genomics Consortium based in Phoenix, and has helped bring countless other jobs to this community. His commitment was instrumental in helping establish the Scottsdale Clinical Research Institute, a hospital-based research institute that serves as a bridge between cure and care. It is one of the finest programs in the nation in its ability to help patients with advanced cancer. It is emblematic of the translation of discoveries in genomic science to specific treatments for individual patients.
Dr. Von Hoff is committed to the professional advancement of younger colleagues, recruiting young investigators and incorporating teaching into every staff meeting. With his encouragement and guidance, younger scientists develop new research and present findings.
His warmth and humor sustain his staff in one of the most challenging fields of medicine, and his colleagues and staff refer to him as the "heart and soul" of the cancer research program.
Dr. Von Hoff earned his medical degree at Columbia College of Physicians and Surgeons in 1973. Following an internship and residency at the University of California, San Francisco, he spent four years at the prestigious National Cancer Institute in Bethesda, Md.
After experience at the forefront of cancer research at NCI, he joined the faculty of the University of Texas in San Antonio, where during the next 20 years he expanded the knowledge of cancer biology and tumor growth factors.
Dr. Von Hoff moved to Arizona in 1999, serving as Director of the Arizona Cancer Center in Tucson, and as Professor at the University of Arizona College of Medicine in Tucson, before joining TGen.
In addition to his other duties, Dr. Von Hoff is serving a six-year presidential appointment (June 2004-March 2010) on the National Institutes of Health's National Cancer Advisory Board. He also is past president of the American Association for Cancer Research, which with more than 28,000 members is the world's largest cancer research organization. He has published more than 540 scientific papers, more than 130 book chapters, and nearly 950 scientific abstracts. He is the holder of a dozen patents for new anti-cancer agents and medical devices.
For more than 35 years, Dr. Von Hoff has been devoted to advancing the understanding and treatment of cancer. His programs have two main goals:
-- Applying new knowledge to identify the best new targeted anti-cancer agents to treat individual cancer patients.
-- Curing pancreatic cancer.
The William F. McWhortor Community Service Leader of the Year award is named in honor of the late co-founder of the Arizona Innovation Network and its successor professional groups in Arizona, including the Arizona Technology Council, which have supported creative technological thinking. McWhortor, a Fountain Hills resident who died in 1997, patented a pattern recognition device in 1989 to help stop counterfeit checks.
Past winners of the McWhortor award include:
-- Ira A. Fulton, chairman and chief executive officer of Tempe-based Fulton Homes Inc.
-- Former Arizona State University President Lattie Coor.
-- Richard Mallery, partner and founding director of the Phoenix law firm Snell & Wilmer, for his successful efforts to bring the Translational Genomics Research Institute to Arizona.
The Translational Genomics Research Institute (TGen) is a non-profit organization dedicated to conducting groundbreaking research with life changing results. Research at TGen is focused on helping patients with diseases such as cancer, neurological disorders and diabetes. TGen is on the cutting edge of translational research where investigators are able to unravel the genetic components of common and complex diseases. Working with collaborators in the scientific and medical communities, TGen believes it can make a substantial contribution to the efficiency and effectiveness of the translational process.
Senior Science Writer
Translational Genomics Research Institute